NCT06687187View on ClinicalTrials.gov

Effect of Two Different Doses of Neostigmine on the Gastric Residual Volume and Aspiration in Critically Ill Patients

CompletedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

April 1, 2024

Study Completion Date

May 1, 2024

Conditions
Gastric Reflux
Interventions
DRUG

Neostigmine

two groups (Group I, n= 41) and (Group II, n= 43) received varying doses of neostigmine (1 mg and 2 mg respectively

Trial Locations (1)

12546

Al-Azhar faculty of medicine, Cairo

All Listed Sponsors
lead

Zulekha Hospitals

OTHER